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Public Health Watch, a project of the Public Health Program of the Open Society 
Institute, aims to strengthen meaningful and sustained engagement by infected and 
affected communities in the development, implementation, and monitoring of TB  
and HIV policies, programs, and practices. Public Health Watch supports advocates to  
identify, document, and articulate priority human rights issues, and to press for account-
ability at the national, regional, and global levels. Public Health Watch believes engaged, 
well-informed individuals and community groups are needed to ensure that government 
policies really live up to the commitments made at the international level; to scrutinize 
whether and how policies and guidance are implemented; and to point out where the 
numbers may not reflect the full reality on the ground.
Monitoring National Responses  
to TB/HIV: Key Findings 
Civil society engagement in the design, implementation, and 
evaluation of TB/HIV policies at the national and inter-
national levels has been minimal. Yet, community-based 
groups are uniquely positioned to offer critical input on 
challenges faced by patients co-infected with TB and HIV 
in accessing care. Since 2004, Public Health Watch has 
supported 53 individuals and organizations in 38 countries 
to conduct monitoring and advocacy of policies on TB and 
HIV. Community groups have used international guidelines 
and commitments, such as the World Health Organization’s 
(WHO’s) Interim Policy on Collaborative TB/HIV Activities, 
the Amsterdam Declaration to Stop TB, and the United 
Nations Declaration of Commitment on HIV/AIDS, as 
monitoring standards to ensure governmental accountability. 
OSI’s approach stresses multiple opportunities for dialogue 
and exchange with a broad range of policy actors, includ-
ing representatives of affected communities, public health 
institutions, and government officials. 
The following are the main findings of the OSI-sup-
ported, community-led monitoring projects:
1) TB and HIV services often run as parallel programs; 
coordination and referral mechanisms between 
programs are limited or nonexistent. Even policies 
that call for coordination between TB and HIV 
programs often do not translate into practice at the 
local level. 
• In Ukraine, there is limited coordination and 
referrals between HIV, TB, and drug treatment 
programs: “The majority of people living with 
HIV/AIDS are drug users, and about half of them 
have TB, so it’s important that these programs 
cooperate better. People shouldn’t have to visit up 
to three clinics to get proper treatment.”1 
• Despite recognizing the growing challenge that 
HIV could present for TB control in Bangladesh, 
strong links between the National AIDS and 
Sexually Transmitted Disease Program and the 
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National TB Program have not been established 
and the budget for implementing such links 
has been minimal.  There is no system in place 
to encourage nongovernmental organizations 
working in the field of HIV testing, counseling 
and care to refer people with TB symptoms to 
treatment centers, or to ensure HIV and TB treat-
ments are coordinated.2 
2) Health care providers, media, policymakers, and 
affected communities lack sufficient knowledge of 
how TB and HIV interact, including how to prevent 
TB among people living with HIV and how to 
effectively treat the two diseases in a coordinated 
manner. 
• In Thailand, health workers are not well informed 
about or trained on how to put the national  
TB/HIV strategy into action. According to one  
TB doctor, TB clinical workers have not been 
trained on how to conduct HIV counseling and 
testing, while HIV clinical workers have little 
experience with TB.3 In addition, health care 
providers often lack the training or resources to 
diagnose TB/HIV co-infection, and are unfamiliar 
with the interactions between TB drugs and  
antiretroviral drugs for HIV.
• In Nigeria, public awareness of TB is generally 
low, even among people living with HIV. Although 
many support groups for people living with 
HIV—especially in urban centers—alert members 
to warning signs of TB infection,4 the general pub-
lic and even members of  these support groups 
often lack basic knowledge about TB, such as the 
location of treatment centers.
• In Lithuania, the TB and HIV programs do not 
contain specific recommendations for informing 
patients and the public about TB/HIV co-infec-
tion. A member of the Lithuanian Positive Group 
stated, “I never got any information about TB in 
the AIDS Center, which I visit regularly. I take 
interest in the problem at my own initiative as  
we have had members of our group with this 
problem who have unfortunately died already.”5
• In Zambia, only officials from the Ministry of 
Health appear to have access to and are aware of 
important health plans and practices, such as the 
WHO’s TB and HIV treatment guidelines. Health 
care providers responsible for implementation 
remain unaware of such vital information and 
those in need of services do not have the informa-
tion to demand the services and treatment they 
deserve.6
3) Community-based organizations and advocates are 
often not included in the development of TB/HIV  
co-infection policies.
• Kenya’s TB/HIV Joint Coordinating Committees, 
which include a central coordinating committee at 
the provincial level and additional committees at 
the local level, lack mechanisms for involvement 
by people living with TB or HIV at both  
the provincial and district levels.7
• In El Salvador, there is a Joint Coordinating Group 
responsible for defining and implementing collab-
orative activities between TB and HIV programs, 
but this body lacks community representation. 
Community health workers are not aware of the 
group’s structure and function, or that a strategic 
plan for TB/HIV collaborative activities has been 
developed.8
4) Stigma is a significant barrier to appropriate diagnosis 
and treatment for TB/HIV co-infection.
• In Vietnam, people living with HIV are kept  
in separate rooms when admitted to TB hospitals. 
TB patients who are co-infected with HIV appear 
more likely to receive substandard TB treatment. 
For example, National TB Program guidelines 
stipulate that TB patients who are HIV-positive 
should not receive injections; therefore, co-
infected patients who cannot tolerate oral medica-
tion are not treated effectively for TB.9  
• In India, people living with HIV report facing 
stigma and discrimination when seeking TB treat-
ment and are sometimes even restricted  
from entering DOTS centers.10
• In Cameroon, TB and HIV-related stigma and  
discrimination sometimes drive people to opt 
against efficient treatment services offered by local 
facilities and to instead travel far from their  
families and communities for treatment.11
• In Tanzania, lack of information on TB and  
TB/HIV co-infection compounds stigma for 
infected individuals. “As soon as it is suspected 
that someone might have TB, everybody thinks 
that he or she also has HIV.”12
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5) Lack of government regulation of TB drug procure-
ment and oversight of service providers leads to drug 
resistance in patients, and incomplete data on the 
epidemic. 
• In Georgia, patients who seek care from private 
providers are not reflected in national policies or 
reporting procedures for TB and HIV. Including 
data from Georgia’s seven private laboratories 
could contribute to more accurate epidemiological 
data that reflects the true extent of the epidemic. 
This data could prove key in advocating for new 
policies and resources. In addition, TB drugs are 
available over the counter, which can lead  
to self-medication and cause patients to develop a 
drug-resistant form of TB.13
• Although private providers in Tanzania must 
receive government approval to implement 
directly observed therapy for TB, many provide 
other TB services without approval or supervi-
sion. Interviews with private health care provid-
ers revealed that most are not well-versed on 
the DOTS strategy or the national TB program’s 
public-private partnership guidelines.14
6) There are often hidden costs of TB treatment that  
create an additional burden for people living with 
HIV. Although TB treatment is free in many 
countries, many patients have to pay for diagnos-
tic tests and transportation, which is particularly 
burdensome for people who must regularly travel 
to separate facilities for HIV treatment. 
• In Vietnam, TB facilities have some of the least 
resources in the health sector. In order to increase 
revenues, facilities offering free treatment for TB 
charge for TB diagnostic tests (which is equivalent 
to about two months’ income for some patients) and 
non-TB services, including testing and treatment 
for HIV and hepatitis. Facilities also sometimes 
increase costs by insisting on in-patient services. 
Since people living with HIV are more likely to test 
smear negative for TB, they require additional TB 
diagnostic tests, thus increasing their costs.15  
• In Zambia, HIV testing is widely available, but TB 
testing has not been made available at the same 
rate.  As a result, people living with HIV in rural 
areas are referred to the nearest provincial hospital 
for TB testing where tests cost between US$2.50 
and US$5.00. Since 64 percent of the population 
lives on less than US$1.00 per day, a TB diagnos-
tic test for people in rural areas costs several days 
of income. By obtaining services at a provincial  
center, patients incur travel and testing costs, 
which can deter them from accessing services.16
Outcomes of Monitoring and Advocacy
Though the importance of community involvement  
in addressing and highlighting the above issues is 
increasingly acknowledged, there are still far too  
few mechanisms and opportunities for meaningful 
participation. However, researching and documenting 
TB/HIV policies, including the translation of such  
policies into practices on the ground, have enabled  
community activists to become more credible advocates 
at the national and international levels. 
Community groups and advocates have already 
demonstrated a positive impact in shaping civil society 
engagement in TB/HIV policies. 
The following are examples of the impact of advocacy 
efforts by OSI-supported community groups:
1) Greater community representation in TB, HIV, and 
TB/HIV policymaking, through participation in 
national and international bodies, including: 
	 International	Bodies
• Stop TB Partnership Working Groups: DOTS 
Expansion; New Diagnostics; New Drugs; 
Advocacy, Communication & Social Mobilization; 
and Multidrug–Resistant TB;
• Stop TB Partnership’s Coordinating Board,  
which monitors the implementation of agreed  
policies, plans and activities of the Partnership, 
and ensures coordination among Stop TB 
Partnership components;
• Community Task Force—a global network of 
TB/HIV advocates representing TB and TB/HIV 
community concerns within the framework of the 
WHO’s Stop TB Partnership;
• UNITAID Board;
• Global Fund to Fight AIDS, TB and Malaria’s  
support delegation;
• WHO’s Strategic and Technical Advisory Group 
on TB (STAG); and
• National delegations to the 2006 United Nations 
high-level review on HIV/AIDS.
National	Bodies
• UN Development Program’s Working Group on 
HIV/AIDS Prevention in Georgia;
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• National TB/HIV Working Committee in Nigeria; 
and 
• Country Coordinating Mechanism for the Global 
Fund in Brazil.
2) Positive change at the local, national, and interna-
tional policy level. 
• As the result of a civil society meeting, a TB/HIV 
target was included in the political declaration 
adopted by the UN General Assembly following 
the “Abuja +5” convening of African Heads of 
State in May 2006. The civil society meeting was 
organized by a Public Health Watch researcher 
from Journalist Against AIDS in Nigeria. 
• Community representatives have been included 
among featured speakers at national and interna-
tional events, such as the World Lung Conference, 
the UNAIDS Programme Coordinating Board 
(PCB), and the Brazilian National Conference on 
TB Control. 
• Researchers shared their TB/HIV monitor-
ing findings with the United States Agency for 
International Development’s TB and HIV depart-
ments and the WHO Stop TB Department.
• The WHO is developing guidelines for national TB 
programs on how to effectively involve communi-
ties in TB programs as a result of advocacy efforts.  
3) Higher profile of TB/HIV in the media. 
• The release of in-depth TB and HIV monitoring 
reports resulted in dozens of national and interna-
tional newspaper and magazine articles, as well as 
radio and television interviews.
• The researchers from Nigeria and Tanzania co-
authored an opinion piece on the urgent need to 
address TB/HIV co-infection in Africa that was 
published in United Kingdom’s The	Guardian and 
Namibia’s The	Namibian. 
4) Greater interest in TB/HIV by AIDS activists and 
international bodies.
• Support for community-led monitoring of TB 
and TB/HIV policies and their implementation 
helped to stimulate demand from community-
based organizations to become actively engaged 
in TB issues. Most of these organizations had 
previously focused primarily on HIV. 
• OSI’s TB/HIV grant-making competition 
informed the launch in March 2007 of the Stop 
TB Partnership’s Challenge Facility for Civil 
Society, which “provides financial support to 
small groups of civil society organizations  
such as NGOs, self-help groups and women's 
groups seeking to make the collective voice of 
the TB community heard. It is targeted at  
civil society groups operating at the grass roots 
level and seeking to shape policy-making at 
local and national levels by giving a voice to 
people living with TB and those involved in their 
care.”17 In 2007, the Challenge Facility distrib-
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For more information, go to www.soros.org/health
